Literature DB >> 29683458

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol.

Elisabeth Naschberger1, Daniela Regensburger1, Clara Tenkerian1, Melanie Langheinrich2, Felix B Engel3, Carol Geppert4, Arndt Hartmann4, Robert Grützmann2, Vera S Schellerer2, Michael Stürzl5.   

Abstract

Primary cells isolated from human carcinomas are valuable tools to identify pathogenic mechanisms contributing to disease development and progression. In particular, endothelial cells (EC) constituting the inner surface of vessels, directly participate in oxygen delivery, nutrient supply, and removal of waste products to and from tumors, and are thereby prominently involved in the constitution of the tumor microenvironment (TME). Tumor endothelial cells (TECs) can be used as cellular biosensors of the intratumoral microenvironment established by communication between tumor and stromal cells. TECs also serve as targets of therapy. Accordingly, in culture these cells allow studies on mechanisms of response or resistance to anti-angiogenic treatment. Recently, it was found that TECs isolated from human colorectal carcinoma (CRC) exhibit memory-like effects based on the specific TME they were derived from. Moreover, these TECs actively contribute to the establishment of a specific TME by the secretion of different factors. For example, TECs in a prognostically favorable Th1-TME secrete the anti-angiogenic tumor-suppressive factor secreted protein, acidic and rich in cysteine-like 1 (SPARCL1). SPARCL1 regulates vessel homeostasis and inhibits tumor cell proliferation and migration. Hence, cultures of pure, viable TECs isolated from human solid tumors are a valuable tool for functional studies on the role of the vascular system in tumorigenesis. Here, a new up-to-date protocol for the isolation of primary EC from the normal colon as well as CRC is described. The technique is based on mechanical and enzymatic tissue digestion, immunolabeling, and fluorescence activated cell sorting (FACS)-sorting of triple-positive cells (CD31, VE-cadherin, CD105). With this protocol, viable TEC or normal endothelial cell (NEC) cultures could be isolated from colon tissues with a success rate of 62.12% when subjected to FACS-sorting (41 pure EC cultures from 66 tissue samples). Accordingly, this protocol provides a robust approach to isolate human EC cultures from normal colon and CRC.

Entities:  

Mesh:

Year:  2018        PMID: 29683458      PMCID: PMC5933406          DOI: 10.3791/57400

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

2.  Isolation of endothelial cells from human tumors.

Authors:  Elisabeth Naschberger; Vera S Schellerer; Tilman T Rau; Roland S Croner; Michael Stürzl
Journal:  Methods Mol Biol       Date:  2011

3.  Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades.

Authors:  Sabine Miebach; Stefan Grau; Vera Hummel; Peter Rieckmann; Joerg-Christian Tonn; Roland Helmut Goldbrunner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

4.  Isolation and characterization of human breast tumor-derived endothelial cells.

Authors:  Cristina Grange; Benedetta Bussolati; Stefania Bruno; Valentina Fonsato; Anna Sapino; Giovanni Camussi
Journal:  Oncol Rep       Date:  2006-02       Impact factor: 3.906

Review 5.  Angiogenesis in life, disease and medicine.

Authors:  Peter Carmeliet
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

6.  VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.

Authors:  Marilyn B Nourse; Daniel E Halpin; Marta Scatena; Derek J Mortisen; Nathaniel L Tulloch; Kip D Hauch; Beverly Torok-Storb; Buddy D Ratner; Lil Pabon; Charles E Murry
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-29       Impact factor: 8.311

7.  A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells.

Authors:  L Richard; P Velasco; M Detmar
Journal:  Exp Cell Res       Date:  1998-04-10       Impact factor: 3.905

8.  Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture.

Authors:  Vera Simone Schellerer; Roland Siegfried Croner; Kristina Weinländer; Werner Hohenberger; Michael Stürzl; Elisabeth Naschberger
Journal:  Lab Invest       Date:  2007-09-17       Impact factor: 5.662

Review 9.  Imaging of angiogenesis: from microscope to clinic.

Authors:  Donald M McDonald; Peter L Choyke
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

10.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  2 in total

1.  Cryopreservation of Whole Tumor Biopsies from Rectal Cancer Patients Enable Phenotypic and In Vitro Functional Evaluation of Tumor-Infiltrating T Cells.

Authors:  Frank Liang; Azar Rezapour; Peter Falk; Eva Angenete; Ulf Yrlid
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

2.  Outgrowth, proliferation, viability, angiogenesis and phenotype of primary human endothelial cells in different purchasable endothelial culture media: feed wisely.

Authors:  Barbara Leopold; Jasmin Strutz; Elisa Weiß; Juergen Gindlhuber; Ruth Birner-Gruenberger; Hubert Hackl; Hannah M Appel; Silvija Cvitic; Ursula Hiden
Journal:  Histochem Cell Biol       Date:  2019-09-21       Impact factor: 4.304

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.